• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Pfizer (PFE)

Common Stock
Sell: $24.91|Buy: $24.94|Change: 0.33 (-1.31%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

Address

66 Hudson Boulevard East
New York
NY
USA
10001-2192

Telephone

+1 800 8793477

Website

https://www.pfizer.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Pfizer Inc Third Quarter Earnings Conference Call for 20262026-11-04T10:00:00
Pfizer Inc Third Quarter Earnings Results for 20262026-11-04T00:00:00
Pfizer Inc Second Quarter Earnings Conference Call for 20262026-08-05T10:00:00
Pfizer Inc Second Quarter Earnings Results for 20262026-08-05T00:00:00
Pfizer Inc First Quarter Earnings Conference Call for 20262026-04-29T10:00:00
Pfizer Inc First Quarter Earnings Results for 20262026-04-29T00:00:00
Pfizer Inc Annual General Meeting for 20262026-04-24T09:00:00
Pfizer Inc Annual Report for 20252026-02-27T00:00:00
Pfizer Inc Fourth Quarter Earnings Conference Call for 20252026-02-03T10:00:00
Pfizer Inc Fourth Quarter Earnings Result for 20252026-02-03T00:00:00
Analyst and Investor Call to Review Pfizer Full-Year 2026 Financial Guidance2025-12-16T08:00:00

Previous key dates

NameKey Date
Analyst and Investor Call to Review Pfizer Full-Year 2026 Financial Guidance2025-12-16T08:00:00
Jefferies London Healthcare Conference2025-11-19T09:00:00
Pfizer Inc Third Quarter Earnings Conference Call for 20252025-11-04T10:00:00
Pfizer Inc Third Quarter Earnings Result for 20252025-11-04T00:00:00
Pfizer Analyst and Investor Call to Discuss Proposed Acquisition of Metsera2025-09-22T08:00:00
Pfizer Inc Second Quarter Earnings Conference Call for 20252025-08-05T10:00:00
Pfizer Inc Second Quarter Earnings Result for 20252025-08-05T00:00:00
Goldman Sachs 46th Annual Global Healthcare Conference2025-06-09T08:00:00
Pfizer Inc First Quarter Earnings Conference Call for 20252025-04-29T10:00:00
Pfizer Inc First Quarter Earnings Result for 20252025-04-29T00:00:00
Pfizer Inc Annual General Meeting for 20252025-04-24T09:00:00
TD Cowen 45th Annual Health Care Conference2025-03-03T10:30:00
Pfizer Inc Annual Report for 20242025-02-27T00:00:00
Pfizer Inc Fourth Quarter Earnings Conference Call for 20242025-02-04T10:30:00
Pfizer Inc Fourth Quarter Earnings Result for 20242025-02-04T00:00:00
Pfizer Inc Q4 Guidance Call for 20242025-01-17T08:30:00
Pfizer Discussion at Healthcare Conference 20252025-01-13T09:45:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.